Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Sinapine P-hydroxybenzylglucosinolate
1. [3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] 2-(4-hydroxyphenyl)-n-sulfooxyethanimidothioate
2. P-hydroxybenzyl Glucosinolate
3. 19253-84-0
4. Dtxsid90871983
5. [(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (1e)-2-(4-hydroxyphenyl)-n-sulfooxyethanimidothioate
6. 1-s-[2-(4-hydroxyphenyl)-n-(sulfooxy)ethanimidoyl]-1-thiohexopyranose
| Molecular Weight | 425.4 g/mol |
|---|---|
| Molecular Formula | C14H19NO10S2 |
| XLogP3 | -0.6 |
| Hydrogen Bond Donor Count | 6 |
| Hydrogen Bond Acceptor Count | 12 |
| Rotatable Bond Count | 7 |
| Exact Mass | 425.04503815 g/mol |
| Monoisotopic Mass | 425.04503815 g/mol |
| Topological Polar Surface Area | 220 Ų |
| Heavy Atom Count | 27 |
| Formal Charge | 0 |
| Complexity | 602 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 5 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 1 |
| Covalently Bonded Unit Count | 1 |
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
90
PharmaCompass offers a list of AC1L99WB API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right AC1L99WB manufacturer or AC1L99WB supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred AC1L99WB manufacturer or AC1L99WB supplier.
PharmaCompass also assists you with knowing the AC1L99WB API Price utilized in the formulation of products. AC1L99WB API Price is not always fixed or binding as the AC1L99WB Price is obtained through a variety of data sources. The AC1L99WB Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A AC1L99WB manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of AC1L99WB, including repackagers and relabelers. The FDA regulates AC1L99WB manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. AC1L99WB API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A AC1L99WB supplier is an individual or a company that provides AC1L99WB active pharmaceutical ingredient (API) or AC1L99WB finished formulations upon request. The AC1L99WB suppliers may include AC1L99WB API manufacturers, exporters, distributors and traders.
AC1L99WB Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of AC1L99WB GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right AC1L99WB GMP manufacturer or AC1L99WB GMP API supplier for your needs.
A AC1L99WB CoA (Certificate of Analysis) is a formal document that attests to AC1L99WB's compliance with AC1L99WB specifications and serves as a tool for batch-level quality control.
AC1L99WB CoA mostly includes findings from lab analyses of a specific batch. For each AC1L99WB CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
AC1L99WB may be tested according to a variety of international standards, such as European Pharmacopoeia (AC1L99WB EP), AC1L99WB JP (Japanese Pharmacopeia) and the US Pharmacopoeia (AC1L99WB USP).
